These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 6242878)
21. Under-explored experimental topics related to integral mycobacterial vaccines for leprosy. Gormus BJ; Meyers WM Expert Rev Vaccines; 2003 Dec; 2(6):791-804. PubMed ID: 14711362 [TBL] [Abstract][Full Text] [Related]
22. [Towards a vaccine against leprosy]. Bloom BR Servir; 1985; 33(5):247-8, 253-5. PubMed ID: 3933117 [No Abstract] [Full Text] [Related]
23. Pathogenesis of a Third World disease: lessons from leprosy. Bloom BR Harvey Lect; 1988-1989; 84():41-63. PubMed ID: 3079280 [No Abstract] [Full Text] [Related]
24. [Intercellular relations in the immunology of leprosy]. Hoffenbach A Acta Leprol; 1986; 4(3):323-9. PubMed ID: 2951961 [No Abstract] [Full Text] [Related]
25. The development of an active vaccine against leprosy. Convit J; Monzón H; Pinardi ME; Aránzazu N; Ulrich M Acta Cient Venez; 1979; 30(5):491-3. PubMed ID: 397704 [No Abstract] [Full Text] [Related]
26. Vaccines in leprosy. Desikan KV Indian J Lepr; 1987; 59(2):127-32. PubMed ID: 3309082 [No Abstract] [Full Text] [Related]
27. Monoclonal antibodies against Mycobacterium leprae and their applications in leprosy research. Sengupta U; Sinha S Indian J Lepr; 1984; 56(4):727-41. PubMed ID: 6398337 [No Abstract] [Full Text] [Related]
28. [Protective properties of M. lufu in experimental leprosy]. Iushin MIu; Kalianina OV Probl Tuberk; 1995; (2):47-8. PubMed ID: 7777465 [TBL] [Abstract][Full Text] [Related]
29. Human vaccination studies in normal and contacts of leprosy patients. Samuel NM; Stanford JL; Rees RJ; Fairbairn T; Adiga RB Indian J Lepr; 1984; 56(1):36-47. PubMed ID: 6384380 [No Abstract] [Full Text] [Related]
30. Prospects for new generation vaccines for leprosy: progress, barriers, and future strategies. Watson JD Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):834-43. PubMed ID: 2681465 [No Abstract] [Full Text] [Related]
31. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients. Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181 [TBL] [Abstract][Full Text] [Related]
32. Progress in the preparation of an antileprosy vaccine from armadillo-derived Mycobacterium leprae. Rees RJ Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):515-8. PubMed ID: 6368415 [No Abstract] [Full Text] [Related]
33. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines. Mustafa AS Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259 [TBL] [Abstract][Full Text] [Related]
34. Thoughts on the immunology of leprosy. Yahr MG Int J Lepr Other Mycobact Dis; 1980 Dec; 48(4):435-9. PubMed ID: 7009450 [No Abstract] [Full Text] [Related]
35. Leprosy vaccines. Pfaltzgraff RE Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):573. PubMed ID: 2205690 [No Abstract] [Full Text] [Related]
36. Vaccines against leprosy. Desikan KV Natl Med J India; 1994; 7(4):153-6. PubMed ID: 7950943 [No Abstract] [Full Text] [Related]
37. Leprosy vaccine. Draper P Nature; 1986 Jan 9-15; 319(6049):94. PubMed ID: 3510399 [No Abstract] [Full Text] [Related]
38. Vaccines against leprosy. Stewart-Tull DE Adv Biotechnol Processes; 1990; 13():201-22. PubMed ID: 2185784 [No Abstract] [Full Text] [Related]